Sinocelltech Group Limited
Research Sinocelltech Group Limited (688520.SS) on Bullrun: market cap CNY 15.27B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker688520.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCNY
- Market capCNY 15.27B
- Financial periodQ2 2026
- RevenueCNY 336.20M
- Net income-CNY 190.01M
- Free cash flow-CNY 131.94M
- Gross margin91.0%
Valuation Snapshot
latest market cap is CNY 15.27B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 15.27B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CNY.
About Sinocelltech Group Limited
Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, viral infections, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma;
ETFs that hold Sinocelltech Group Limited
US-listed ETFs
Sinocelltech Group Limited is held by 10 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Vanguard ESG International Stock ETF (VSGX) | <0.01% | 0.10% |
| State Street SPDR S&P China ETF (GXC) | 0.01% | 0.59% |
| Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF (ASHS) | 0.05% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sinocelltech Group Limited's market cap?
Sinocelltech Group Limited's market capitalization is CNY 15.27B.
What does Sinocelltech Group Limited do?
Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, viral infections, and vaccines in China.